Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response

Chronic spontaneous urticaria (CSU) is a common disease both in the pediatric and in the adult population. However, there are differences between the two patient populations with respect to etiological factors, comorbidities, and treatment responses. Our aim was to determine differences between pediatric and adult CSU in terms of clinical characteristics, laboratory parameters, comorbidities, response to treatment, and indicators of response.

[1]  T. Zuberbier,et al.  The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria , 2021, Allergy.

[2]  M. Rudenko,et al.  Effects of pregnancy on chronic urticaria: Results of the PREG‐CU UCARE study , 2021, Allergy.

[3]  R. Asero,et al.  Biomarkers of chronic spontaneous urticaria and their clinical implications , 2021, Expert review of clinical immunology.

[4]  M. Maurer,et al.  Total IgE as a Marker for Chronic Spontaneous Urticaria , 2021, Allergy, asthma & immunology research.

[5]  P. Keith,et al.  Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review , 2020, Allergy, Asthma & Clinical Immunology.

[6]  E. Novembre,et al.  Efficacy and tolerability of the updosing of second‐generation non‐sedating H1 antihistamines in children with chronic spontaneous urticaria , 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[7]  S. Greenberger,et al.  Children with chronic urticaria can be effectively controlled with updosing second-generation antihistamines. , 2020, Journal of the American Academy of Dermatology.

[8]  L. Dumoutier,et al.  Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria. , 2020, European annals of allergy and clinical immunology.

[9]  T. Zuberbier,et al.  Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysis , 2020, Allergy.

[10]  M. Hide.  Faculty Opinions recommendation of Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[11]  Laurent Martin,et al.  The burden of chronic urticaria: French baseline data from the international real-life AWARE study , 2019, European Journal of Dermatology.

[12]  M. Maurer,et al.  Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria , 2019, The World Allergy Organization journal.

[13]  A. Licari,et al.  Basophil activation test in children with autoimmune chronic spontaneous urticaria: Is it ready for clinical practice? , 2019, Immunobiology.

[14]  S. Frischbutter,et al.  Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity and poor response to treatment. , 2019, The journal of allergy and clinical immunology. In practice.

[15]  F. Bérard,et al.  Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU , 2018, Allergy.

[16]  T. Zuberbier,et al.  Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients , 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[17]  M. Maurer,et al.  C‐reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria , 2018, Allergy.

[18]  P. Kolkhir,et al.  CRP, D-dimer, fibrinogen and ESR as predictive markers of response to standard doses of levocetirizine in patients with chronic spontaneous urticaria. , 2017, European annals of allergy and clinical immunology.

[19]  O. Schmetzer,et al.  Autoimmune chronic spontaneous urticaria: What we know and what we do not know , 2017, The Journal of allergy and clinical immunology.

[20]  T. Jakob,et al.  H1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  A. Knulst,et al.  Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria , 2017, Clinical and Translational Allergy.

[22]  Young-Ho Jung,et al.  Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children , 2017, Allergy, asthma & immunology research.

[23]  E. Rahme,et al.  Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity , 2016, International Archives of Allergy and Immunology.

[24]  R. Sultana,et al.  A stepwise approach in the management of chronic spontaneous urticaria in children , 2016, Asia Pacific allergy.

[25]  C. Giaquinto,et al.  Epidemiology of Frequently Occurring Skin Diseases in Italian Children from 2006 to 2012: A Retrospective, Population‐Based Study , 2015, Pediatric dermatology.

[26]  S. Till,et al.  BSACI guideline for the management of chronic urticaria and angioedema , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  B. Carter,et al.  H1-antihistamines for chronic spontaneous urticaria. , 2014, The Cochrane database of systematic reviews.

[28]  I. Hassan,et al.  Correlation of C-Reactive Protein Levels with Severity of Chronic Urticaria , 2014, Indian journal of dermatology.

[29]  Z. Zhai,et al.  Evaluation of Autologous Serum Skin Test and Skin Prick Test Reactivity to House Dust Mite in Patients with Chronic Spontaneous Urticaria , 2013, PloS one.

[30]  G. Ciprandi,et al.  The Age Impact on Serum Total and Allergen-Specific IgE , 2013, Allergy, asthma & immunology research.

[31]  M. Leshno,et al.  Chronic urticaria and autoimmunity: associations found in a large population study. , 2012, The Journal of allergy and clinical immunology.

[32]  A. Kasperska‐Zając,et al.  Plasma IL‐6 concentration correlates with clinical disease activity and serum C‐reactive protein concentration in chronic urticaria patients , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[33]  R. Asero.  Sex differences in the pathogenesis of chronic urticaria. , 2003, The Journal of allergy and clinical immunology.